FSLR · Investment summary · as of 3 August 2026
Priced slightly ahead of what the business has demonstrated
Business type: Transition · cyclical or commodity-sensitive
The business does not meet the quality standard for its economic type.
At $211.16, FSLR requires a 24% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at 2%.
C4-1 requires the memo to declare which disagreement with the market the thesis actually IS, and on this name the entire question is WHICH MARGIN IS TERMINAL — the subsidised one or the product one.
Estimates have moved nEGATIVE into and after the print, which is the PEAD-relevant direction: Q3 2026 consensus EPS fell from $5.16 thirty days ago to $4.70 today (-9.0%); Q4 2026 from $5.99 to $5.73 (-4.3%); FY2027 from $23.23 (30d) and $23.30 (90d) to $23.05. OUR 12-MONTH TARGET IS above STREET AND THE GAP IS SMALL AND ENTIRELY MULTIPLE.
The strongest argument against this view: a US utility-scale demand cliff at First Solar's CUSTOMERS, not at First Solar.
| Question | Evidence-based conclusion |
|---|---|
| What drives the business? | C4-1 requires the memo to declare which disagreement with the market the thesis actually IS, and on this name the entire question is WHICH MARGIN IS TERMINAL — the subsidised one or the product one. |
| What do we forecast? | Revenue growth of 2% demonstrated; a terminal operating margin of 9%; an exit multiple of 15.5x. |
| What does Street forecast? | NEGATIVE into and after the print, which is the PEAD-relevant direction: Q3 2026 consensus EPS fell from $5.16 thirty days ago to $4.70 today (-9.0%); Q4 2026 from $5.99 to $5.73 (-4.3%); FY2027 from $23.23 (30d) and $23.30 (90d) to $23.05. |
| Where do we differ? | OUR 12-MONTH TARGET IS above STREET AND THE GAP IS SMALL AND ENTIRELY MULTIPLE. On terminal margin, the difference between what the price requires and what the business has demonstrated is -16.6 percentage points. |
| What is it worth? | Twelve-month target $268.00, +27% from the struck price. Scenario-weighted expected return net of costs +15.7%. |
| Why now? | Date not announced — no dated event that would resolve the disagreement is on file |
| Date or window | Event | Thesis confirmed if | Thesis weakened or refuted if |
|---|---|---|---|
| 29 October 2026 | Next results (date estimated, not issuer-confirmed) | Revenue and margin in line with, or above, the house path | A miss that moves the full-year path below the guided floor |
| FY2026 10-K, filed ~February 2027 | Contracted backlog below 38.0 GW at 31 December 2026 | Contracted backlog at or above 38.0 GW at 31 December 2026 | Contracted backlog below 38.0 GW at 31 December 2026 |
| FY2026 results release, ~February 2027 | FY2027 guidance implies net sales below $4.5bn, or Section 45X… | FY2027 guidance implies net sales at or above $4.5bn, or Section 45X credits below $1.8bn | FY2027 guidance implies net sales below $4.5bn, or Section 45X credits below $1.8bn |
| Tested each quarter from Q3 2026 (reported ~late October 2026) | Product gross margin below 5% for two consecutive quarters | Product gross margin at or above 5% for two consecutive quarters | Product gross margin below 5% for two consecutive quarters |
Dates marked as estimated are drawn from the company’s own reporting cadence, not from an announcement.
A US utility-scale demand cliff at First Solar's CUSTOMERS, not at First Solar. FSLR does not receive the 48E/45Y credits; its customers do. THAT DEADLINE HAS PASSED. The mechanism, specifically: from Q3 2026 the addressable market for new ground-breaks is structurally and permanently smaller; the safe-harboured cohort is worked through over 2026-2030 while backlog is not replenished (derived Q2 net bookings ~0.9 GW against ~3.7 GW shipped, a ~0.24x book-to-bill, on a contracted book that has fallen 72.8 -> 45.1 GW in eight quarters, -38.0%); Section 45X then phases down 75/50/25 in 2030/31/32 and is unavailable after 2032, removing ~99% of current operating income on a legislated schedule that sits INSIDE the five-year horizon; and First Solar reverts to its merchant P&L — a 7-10% product gross margin on ~$5bn of revenue against ~$620m of operating expenses, i.e.
Estimated probability 22%, against the 15% level at which the position would be resized. It sits above that level, so this case could not be carried at full size.
Falsifiable and fundamental — not one of them is a price condition.
On approach to the $268.00 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.
| Criteria | Status | Investment meaning |
|---|---|---|
| Quality | Not met | Is the business worth owning under its declared economic type? |
| Valuation | Not met | Is the operating path required by today's price achievable? |
| Liquidity | Met | Can the intended position be built and exited in the right vehicle? |
| Downside | Met | A US utility-scale demand cliff at First Solar's CUSTOMERS, not at First Solar. |
| Momentum | Met | Does price action support or complicate entry timing? |
| Catalyst | Not determined | The two statutory dates are the most important entries and are the only ones requiring no forecast: contract-expiry and credit-expiry dates are catalysts, and the moment the contracted tranche starts rolling off is when the thesis gets retested. |
| Consensus | Met | Is the house-versus-Street disagreement identified and quantified? |
Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.
The gap between what today's price requires and what the business has demonstrated is -16.6 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is the permanent-loss mechanism: a US utility-scale demand cliff at First Solar's CUSTOMERS, not at First Solar. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $184.90, which forces an immediate review.